We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Effective Collaboration - Team Research for Better Returns:

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: richardred5/28/2012 10:05:19 PM
  Read Replies (1) of 7094
RE: LNDC I added recently just below 7. I had some time this weekend., with some help of a good TA person for the chart.
Yep, it's speculative, but up my alley.

Moderators: richardred
Followers: 6
Created: 10/8/2007 9:12:22 AM

Board type: Free
Search This Board:

Posts Today: 26

Gary Steele is the President, CEO and Chairman of Landec Corporation, a publicly traded materials science company in Menlo Park, California since 1991. Landec Corporation designs, develops, manufactures and sells temperature-activated and other specialty polymer products for a variety of food, agricultural and licensed partner applications. Landec had revenues of over $235 million in fiscal year 2008 and the Company has been profitable since 2003.

Prior to his employment at Landec, Gary was President and CEO of Molecular Devices Corporation in Sunnyvale, California from 1985 to1991 and before that he was Vice President of Product Development at Genentech Corp., a biotechnology company in So. San Francisco, California from 1981 to1985. After graduation from Stanford University in 1975, Gary worked as Senior Manager at McKinsey & Co., a management
Landec Corporation-LNDC- (Landec) designs, develops, manufactures and sells temperature-activated and other specialty polymer products for a variety of food products, agricultural products, and licensed partner applications. Landec has three core businesses: Food Products Technology, Commodity Trading and Technology Licensing. Its Food Products Technology business is operated through a subsidiary, Apio, Inc. (Apio), and combines the Company's food packaging technology with the capabilities of a national food supplier and produce processor. Landec's Commodity Trading business is operated through Apio and combines Apio's export company, Cal Ex Trading Company (Cal-Ex), with Apio's domestic buy-sell commodity business that purchases and sells whole fruit and vegetable products to Asia and domestically to Wal-Mart. Its Technology Licensing business includes its Intellicoat seed coating technology and its Intelimer polymer business.

In April 2010, the Company acquired Lifecore Biomedical, Inc.
Landec Corporation Acquires GreenLine Foods, Inc. Business Wire Mon, Apr 23, 2012

Possible Hidden Gem & catalyst-The jury is still out about potential, but LNDC recently wrote up the value of their Windset investement on the books.

Windset Farms 20% Equity Interest

How many analysts know who owns 20% of the biggest the most sustainable greenhouses in the world with no carbon footprint? The operation is already yielding good results. How long before the process is expanded?
Windset is considering expanding the California operation, Newell said, and has already found land adjacent to Windset Santa Maria.
Windst Farms First Harvest-

Windset Farms creates jobs in Santa Maria

Windset Farms Websight

The Santa Maria Greenhouse

Landec Company Websight

Guru Focus Piece


BreatheWay® membranes are designed to naturally extend the shelf life of virtually any fresh product that would benefit from reduced oxygen levels and managed carbon dioxide levels. Our unique membrane solution manages all gas transfer requirements for the package, leaving more flexibility for the balance of the package to meet shipping or merchandising requirements.

Lifecore Biomedical

Great profit margins to the bottom line, but IMO the unit needs predictabe profitable growth.

Lifecore Biomedical, a wholly-owned subsidiary of Landec Corporation, is a leading developer and supplier of premium hyaluronan or Sodium Hyaluronate (NaHy) and other biomaterials for medical device applications. Hyaluronan is a physiological substance that is widely distributed in the extracellular matrix and connective tissues in both animals and humans, particularly in the aqueous humor of the eye, synovial fluid, skin, and umbilical cord. The viscoelastic properties and the water solubility of this non-crystalline polymer make it ideal for medical device applications where lubricity, protection and cushioning are critical. Landec considers NaHy an important biomaterial technology platform for future growth.

Related Information of interest
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext